Intra-mammary Distribution of Transdermal Telapristone Versus Oral Telapristone: A Randomized Window Trial in Women Undergoing Mastectomy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Telapristone (Primary) ; Telapristone (Primary)
- Indications Early breast cancer
- Focus Pharmacokinetics
- 22 Jan 2018 Planned number of patients changed from 70 to 67.
- 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Jan 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2019.